BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35097133)

  • 1. Interleukin-32
    Braga YLL; Neto JRC; Costa AWF; Silva MVT; Silva MV; Celes MRN; Oliveira MAP; Joosten LAB; Ribeiro-Dias F; Gomes RS; Machado JR
    J Immunol Res; 2022; 2022():7070301. PubMed ID: 35097133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection.
    Esper L; Utsch L; Soriani FM; Brant F; Esteves Arantes RM; Campos CF; Pinho V; Souza DG; Teixeira MM; Tanowitz HB; Vieira LQ; Machado FS
    Microbes Infect; 2014 Jun; 16(6):481-90. PubMed ID: 24704475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Cardiac IL-10 and Downregulation of IFN-
    da Silva MV; de Almeida VL; de Oliveira WD; Matos Cascudo NC; de Oliveira PG; da Silva CA; da Silva ACS; Dos Reis Monteiro MLG; Correa RRM; Oliveira MAP; Lino-Júnior RS; Celes MRN; Machado JR
    Mediators Inflamm; 2018; 2018():3421897. PubMed ID: 30622430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice.
    Santamaría MH; Corral RS
    Cytokine; 2013 Feb; 61(2):491-8. PubMed ID: 23199812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.
    Michailowsky V; Silva NM; Rocha CD; Vieira LQ; Lannes-Vieira J; Gazzinelli RT
    Am J Pathol; 2001 Nov; 159(5):1723-33. PubMed ID: 11696433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.
    Gomes RS; Silva MVT; Dos Santos JC; van Linge C; Reis JM; Teixeira MM; Pinto SA; Dorta ML; Bai X; Chan ED; Dinarello CA; Oliveira MAP; Joosten LAB; Ribeiro-Dias F
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29483288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection.
    Roffê E; Rothfuchs AG; Santiago HC; Marino AP; Ribeiro-Gomes FL; Eckhaus M; Antonelli LR; Murphy PM
    J Immunol; 2012 Jan; 188(2):649-60. PubMed ID: 22156594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fat on cardiomyopathy outcome in mouse models of chronic Trypanosoma cruzi infection.
    Zaki P; Domingues EL; Amjad FM; Narde MB; Gonçalves KR; Viana ML; de Paula H; de Lima WG; Huang H; Bahia MT; Sherer PE; Dos Santos FM; Weiss LM; Tanowitz HB
    Parasitol Res; 2020 Jun; 119(6):1829-1843. PubMed ID: 32206887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
    Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
    Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Trypanosoma cruzi infection on nitric oxide synthase and arginase expression and activity in young and elderly mice.
    Felizardo AA; Caldas IS; Mendonça AAS; Gonçalves RV; Tana FL; Almeida LA; Novaes RD
    Free Radic Biol Med; 2018 Dec; 129():227-236. PubMed ID: 30248443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
    Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
    Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities.
    Roggero E; Perez A; Tamae-Kakazu M; Piazzon I; Nepomnaschy I; Wietzerbin J; Serra E; Revelli S; Bottasso O
    Clin Exp Immunol; 2002 Jun; 128(3):421-8. PubMed ID: 12067296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. During acute experimental infection with the reticulotropic Trypanosoma cruzi strain Tulahuen IL-22 is induced IL-23-dependently but is dispensable for protection.
    Erdmann H; Behrends J; Hölscher C
    Sci Rep; 2016 Sep; 6():32927. PubMed ID: 27650379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
    J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Blockade of Interleukin-2 During the Acute Phase of
    Nihei J; Cardillo F; Mengel J
    Front Cell Infect Microbiol; 2021; 11():758273. PubMed ID: 34869064
    [No Abstract]   [Full Text] [Related]  

  • 18. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
    Antúnez MI; Cardoni RL
    Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
    Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
    Front Immunol; 2018; 9():913. PubMed ID: 29774028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis.
    Mendonça AAS; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Talvani A; Natali AJ; Novaes RD
    Life Sci; 2019 Aug; 230():141-149. PubMed ID: 31129142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.